| Literature DB >> 20587181 |
Amr Kandeel1, Serge Manoncourt, Eman Abd el Kareem, Abdel Nasser Mohamed Ahmed, Samir El-Refaie, Hala Essmat, Jeffrey Tjaden, Cecilia C de Mattos, Kenneth C Earhart, Anthony A Marfin, Nasr El-Sayed.
Abstract
During March 2006-March 2009, a total of 6,355 suspected cases of avian influenza (H5N1) were reported to the Ministry of Health in Egypt. Sixty-three (1%) patients had confirmed infections; 24 (38%) died. Risk factors for death included female sex, age > or = 15 years, and receiving the first dose of oseltamivir >2 days after illness onset. All but 2 case-patients reported exposure to domestic poultry probably infected with avian influenza virus (H5N1). No cases of human-to-human transmission were found. Greatest risks for infection and death were reported among women > or = 15 years of age, who accounted for 38% of infections and 83% of deaths. The lower case-fatality rate in Egypt could be caused by a less virulent virus clade. However, the lower mortality rate seems to be caused by the large number of infected children who were identified early, received prompt treatment, and had less severe clinical disease.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20587181 PMCID: PMC3321902 DOI: 10.3201/eid1607.091695
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Residences of 63 case-patients with avian influenza virus (H5N1) infections, Egypt, 2006–2009. 1, Alexandria; 2, Kafr El Sheikh; 3, Gharbia; 4, Menofia; 5, Qalubiya; 6, Behera; 7, Damietta; 8, Dakahlia; 9, Sharkia; 10, Cairo; 11, 6th of October; 12, Suez; 13, Fayoum; 14, Benu Suef; 15, Menia; 16, Assyut; 17, Sohag; 18, Qena; 19, Aswan.
Demographic and exposure characteristics for persons with confirmed avian influenza (H5N1), Egypt, 2006–2009
| Characteristic | No. (%) persons |
|---|---|
| Total confirmed cases | 63 |
| Deaths | 24 (38.0) |
| Women | 40 (63.5) |
| Age group, y | |
| 0–4 | 23 (36.5) |
| 5–14 | 11 (17.5) |
| 15–49 | 27 (43.0) |
|
| 2 (3.0) |
| Exposure (no. persons)* | |
| Exposure to a confirmed human case before illness (63) | 4 (6.3) |
| Occupational (63) | 4 (6.3) |
| Exposure to likely infected backyard flocks (63) | 57 (90.5) |
| No known exposure (63) | 2 (3.2) |
| Consumption of raw or undercooked poultry products (61) | 0 |
| Exposure to likely infected backyard flocks (41) | |
| Recently purchased domestic poultry from market/seller (41) | 12 (29.2) |
| Recently purchased poultry became ill (12) | 7 (58.3) |
| Noted illness or death among their birds (41) | 33 (80.5) |
| Bred birds (27) | 14 (51.8) |
| Slaughtered birds in past 10 d (27) | 13 (48.1) |
| Defeathered birds in past 10 d (27) | 13 (48.1) |
*Denominators vary for each exposure because data were not available for all persons.
Figure 2Illness onset for 63 case-patients with confirmed avian influenza (H5N1), by month, Egypt, 2006–2009.
Signs and symptoms at illness onset for 60 persons with confirmed avian influenza (H5N1), by age group, Egypt, 2006–2009*
| Sign or symptom | Age group, y, no. (%) | p value | |
|---|---|---|---|
| <15, n = 34 | ≥15, n = 26 | ||
| Fever | 34 (100) | 24 (92) | >0.05 |
| Cough | 22 (65) | 21 (81) | >0.05 |
| Shortness of breath | 5 (15) | 10 (38) | <0.05 |
| Sore throat | 17 (50) | 10 (38) | >0.05 |
| Vomiting | 3 (9) | 7 (27) | >0.05 |
| Diarrhea | 2 (6) | 4 (15) | >0.05 |
| Muscle/joint pain | 2 (6) | 12 (46) | <0.001 |
| Headache | 1 (3) | 6 (23) | <0.05 |
| Alteration of consciousness | 1 (3) | 1 (4) | >0.05 |
*Data regarding signs and symptoms were available only for 60 of the 63 patients.
Secondary complications in persons infected with avian influenza virus (H5N1), Egypt, 2006–2009*
| No. secondary complications | No. persons | Type of complications (no. persons), outcome | Case-fatality rate by no. complications (%) |
|---|---|---|---|
| 1 | 6 | ARDS (n = 2), 2 died; bacteremia (n = 2), 2 alive; pneumonia (n = 1), 1 alive; shock (n = 1), 1 alive | 2/6 (33) |
| 2 | 11 | ARDS/pneumonia (n = 3), 2 died, 1 alive; ARDS/shock (n = 5), 1 died; ARDS/ renal failure (n = 1), 1 died; ARDS/coagulopathy (n = 1), 1 died; pneumonia/toxic myocarditis (n = 1), 1 alive | 9/11 (82) |
| 3 | 5 | ARDS/pneumonia/shock (n = 3), 3 died; ARDS/shock/renal failure (n = 1), 1 died; shock/renal failure/coagulopathy (n = 1), 1 died | 5/5 (100) |
| 4 | 2 | ARDS/pneumonia/shock/renal failure (n = 1), 1 died; ARDS/shock/renal failure/coagulopathy. (n = 1), 1 died | 2/2 (100) |
| 5 | 1 | ARDS/pneumonia/shock/ renal failure/coagulopathy (n = 1), 1 died | 1/1 (100) |
*ARDS, acute respiratory distress syndrome.
CFRs for 63 persons infected with avian influenza virus (H5N1), Egypt, 2006–2009*
| Characteristic | Total no. | No. died | CFR, % |
|---|---|---|---|
| Sex† | |||
| F | 40 | 21 | 52.5 |
| M | 23 | 3 | 13 |
| Age group, y‡ | |||
| 0–4 | 23 | 0 | 0 |
| 5–14 | 11 | 2 | 18 |
| 15–49 | 27 | 20 | 74 |
|
| 2 | 2 | 100 |
| All ages | 63 | 24 | 38 |
| Days between illness onset and hospitalization§ | |||
| 0–2 | 32 | 4 | 12.5 |
| 3–4 | 12 | 4 | 33 |
| 5–6 | 9 | 8 | 89 |
|
| 9 | 8 | 89 |
| Days between illness onset and first oseltamivir dose¶ | |||
| 0–2 | 25 | 1 | 4 |
| 3–4 | 14 | 3 | 21 |
| 5–6 | 7 | 5 | 71 |
|
| 12 | 11 | 92 |
*CFR, case-fatality rate. †p = 0.0004, by χ2 test for CFR for female patients vs. that for male patients. ‡p<0.001, by χ2 test for patients <15 years of age vs. patients >15 years of age. §p<0.001, by χ2 test for patients hospitalized <2 d after illness onset vs. patients hospitalized after 2 d. ¶p<0.001, by χ2 test for patients who received oseltamivir <2 d after illness onset vs. patients who received oseltamivir after 2 d.